Lidocaine hydrochloride monohydrate

Independent reference data for Lidocaine hydrochloride monohydrate (CAS 6108-05-0), compiled from public chemistry databases.

Registry identifiers across databases

Computed descriptors

Documented uses on record

For production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks.Information on 1 consumer products that contain Lidocaine hydrochloride in the following categories is provided:

Synonyms and trade names

Lidocaine hydrochloride; 73-78-9; LIDOCAINE HCL; Lidothesin; Lignocaine hydrochloride; Laryng-O-jet; Anestacon; Lidocaton; Glydo; Xylocaine Viscous; LIDOCAINE VISCOUS; LTA II KIT; PEDIATRIC LTA KIT; LARYNG-O-JET KIT; Lidocaine hydrochloride anhydrous; LIDOPEN

GHS hazard classification

Reported hazard statements	H301 (82.5%), H302 (17.5%), H315 (40.3%), H319 (40.3%), H334 (37.3%), H335 (40.3%), H412 (37.3%)

H301 (82.5%): Toxic if swallowed [Danger Acute toxicity, oral]

H302 (17.5%): Harmful if swallowed [Warning Acute toxicity, oral]

What the public record says

Lidocaine hydrochloride monohydrate · CAS 6108-05-0 · C14H23ClN2O. UNII EC2CNF7XFP.

Physical description and handling notes

Source: PubChem / Wikidata; the batch COA governs where values differ.